✦ LIBER ✦

Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone

✍ Scribed by Orazio Caffo; Teodoro Sava; Evi Comploj; Maria Anna Giampaolo; Romana Segati; Francesco Valduga; Gianluigi Cetto; Enzo Galligioni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermittent docetaxel therapy with estr

✍ Norihito Soga; Manabu Kato; Kouhei Nishikawa; Yoshihiro Hasegawa; Yasushi Yamada 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 305 KB

Evaluation of docetaxel plus estramustin

✍ Akihiro Matsumoto; Atsushi Inoue; Satoshi Yokoi; Kazuyoshi Nozumi; Kanetaka Miya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Biweekly Doxorubicin/Ketoconazole as Sec

✍ George Lainakis; Antoniou Nikos; Alivizatos Gerassimos; Chrisofos Michael; Mitso 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Response to docetaxel/carboplatin-based

✍ Mari Nakabayashi; Oliver Sartor; Susanna Jacobus; Meredith M. Regan; David McKea 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

MP-08.16: Docetaxel and oral estramustin

✍ T. Segawa; N. Masuda; Y. Shiraishi; H. Negoro; H. Oka; H. Iwamura; S. Moroi; K. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Combination chemotherapy with weekly doc

✍ Atsushi Takenaka; Yuji Yamada; Toshifumi Kurahashi; Hideo Soga; Hideaki Miyake; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB